46.46.Z - Wholesale trade of pharmaceutical and medical products
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.45.Z - Wholesale trade of perfumes and cosmetics
46.75.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,4 | 0,6 | 0,9 | 39,2 |
EBITDA | 0,1 | 0,3 | 0,3 | 25,3 |
Short time liabilities | 0,1 | 0,1 | 0,2 | 125,3 |
Equity capital | 5,4 | 6 | 6,8 | 12,3 |
Operating profit (EBIT) | 0 | 0,2 | 0,3 | 36,4 |
Assets | 5,5 | 6,1 | 6,9 | 13,7 |
Net profit (loss) | -0,4 | 0,6 | 0,7 | 17,1 |
Cash | 1,2 | 0,3 | 0,4 | 3,2 |
Net income from sale | 1,3 | 1,6 | 1,8 | 11,4 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,2 | 121,9 |
Working assets | 1,5 | 0,7 | 0,7 | 6,3 |
Depreciation | 0,1 | 0,1 | 0,1 | 1,1 |
% | % | % | p.p. | |
Profitability of capital | -6,5 | 10,5 | 11 | 0,5 |
Equity capital to total assets | 98,6 | 98,8 | 97,6 | -1,2 |
Gross profit margin | -26,8 | 39,8 | 49,7 | 9,9 |
EBITDA Margin | 10,9 | 16,8 | 18,9 | 2,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 22 | 17 | 34 | 17 |
Current financial liquidity indicator | 19.463951110839844 | 9.159306526184082 | 4.389344692230225 | -4,8 |
Net dept to EBITDA | -8.242334365844727 | -1.2971571683883667 | -1.0686373710632324 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane